FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period

LABORATORIOS FARMACEUTICOS ROVI S.A: ifrs:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod

One fact, its scope and the complete path back to the official record.

Period: 2020-01-01 – 2020-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/6a7aa5ff-29f8-4557-ba9f-035a9bfa195c

Reported value

31.000k{"amount": 31000.0}
Entity
LABORATORIOS FARMACEUTICOS ROVI S.A
Metric
ifrs:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
Period
2020-01-01 – 2020-12-31
Status
current
Source
ESEF — Europäische Jahresabschlüsse (iXBRL)

Provenance

Official referenceesef:95980020140005936480:2021-12-31
Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:45:32.784589+02:00
Raw response SHA-256770cd6decb39662953c01eb8337a4adc…
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies